BlackRock Fund Advisors - CONTRAVIR PHARMACEUTICALS IN ownership

CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 29 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of CONTRAVIR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2016$23,000
+43.8%
19,117
+29.2%
0.00%
Q3 2016$16,000
+220.0%
14,797
+196.9%
0.00%
Q2 2016$5,000
-93.0%
4,984
-91.5%
0.00%
Q1 2016$71,000
-27.6%
58,917
-6.9%
0.00%
Q4 2015$98,000
-22.2%
63,313
+4.8%
0.00%
Q3 2015$126,000
-60.0%
60,435
-2.6%
0.00%
Q2 2015$315,00062,0310.00%
Other shareholders
CONTRAVIR PHARMACEUTICALS IN shareholders Q3 2015
NameSharesValueWeighting ↓
EAM Investors, LLC 670,593$3,401,0000.45%
Prospera Financial Services Inc 184,100$236,0000.05%
HighTower Advisors, LLC 1,047,731$1,257,0000.01%
TWO SIGMA SECURITIES, LLC 15,142$18,0000.01%
TEACHERS ADVISORS, LLC 298,781$1,820,0000.00%
TIAA CREF INVESTMENT MANAGEMENT LLC 724,455$4,412,0000.00%
Virtu KCG Holdings LLC 90,490$109,0000.00%
FIRST FOUNDATION ADVISORS 10,000$12,0000.00%
Acrospire Investment Management LLC 2,300$3,0000.00%
Balentine LLC 55$00.00%
View complete list of CONTRAVIR PHARMACEUTICALS IN shareholders